These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11558563)

  • 41. Changes in the passive electrical properties of human stratum corneum due to electroporation.
    Pliquett U; Langer R; Weaver JC
    Biochim Biophys Acta; 1995 Nov; 1239(2):111-21. PubMed ID: 7488616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transdermal permeation of neutral molecules by skin electroporation.
    Vanbever R; Leroy MA; Préat V
    J Control Release; 1998 Aug; 54(3):243-50. PubMed ID: 9766244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electrorheological modeling of the permeabilization of the stratum corneum: theory and experiment.
    Pawlowski P; Gallo SA; Johnson PG; Hui SW
    Biophys J; 1998 Dec; 75(6):2721-31. PubMed ID: 9826595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-linearity of molecular transport through human skin due to electric stimulus.
    Pliquett UF; Gusbeth CA; Weaver JC
    J Control Release; 2000 Sep; 68(3):373-86. PubMed ID: 10974391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electroporation as an efficient physical enhancer for skin drug delivery.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Revilla-Vázquez AL
    J Clin Pharmacol; 2009 Nov; 49(11):1262-83. PubMed ID: 19717723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparin alters transdermal transport associated with electroporation.
    Weaver JC; Vanbever R; Vaughan TE; Prausnitz MR
    Biochem Biophys Res Commun; 1997 May; 234(3):637-40. PubMed ID: 9175766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of application voltage and cathode and anode positions at electroporation on the in vitro permeation of benzoic acid through hairless rat skin.
    Yoshida M; Mori K; Watanabe T; Hasegawa T; Sugibayash K
    Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1807-9. PubMed ID: 11086923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation.
    Regnier V; De Morre N; Jadoul A; Préat V
    Int J Pharm; 1999 Jul; 184(2):147-56. PubMed ID: 10387943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimizing Irreversible Electroporation Ablation with a Bipolar Electrode.
    Wandel A; Ben-David E; Ulusoy BS; Neal R; Faruja M; Nissenbaum I; Gourovich S; Goldberg SN
    J Vasc Interv Radiol; 2016 Sep; 27(9):1441-1450.e2. PubMed ID: 27475242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The application of anethole, menthone, and eugenol in transdermal penetration of valsartan: Enhancement and mechanistic investigation.
    Ahad A; Aqil M; Ali A
    Pharm Biol; 2016; 54(6):1042-51. PubMed ID: 26510896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A practical assessment of transdermal drug delivery by skin electroporation.
    Prausnitz MR
    Adv Drug Deliv Rev; 1999 Jan; 35(1):61-76. PubMed ID: 10837689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of heat on skin permeability.
    Park JH; Lee JW; Kim YC; Prausnitz MR
    Int J Pharm; 2008 Jul; 359(1-2):94-103. PubMed ID: 18455889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanistic studies of molecular transdermal transport due to skin electroporation.
    Pliquett U
    Adv Drug Deliv Rev; 1999 Jan; 35(1):41-60. PubMed ID: 10837688
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calcein Release from Cells In Vitro via Reversible and Irreversible Electroporation.
    Rajeckaitė V; Jakštys B; Rafanavičius A; Maciulevičius M; Jakutavičiūtė M; Šatkauskas S
    J Membr Biol; 2018 Feb; 251(1):119-130. PubMed ID: 29143077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transdermal alniditan delivery by skin electroporation.
    Jadoul A; Lecouturier N; Mesens J; Caers W; Préat V
    J Control Release; 1998 Aug; 54(3):265-72. PubMed ID: 9766246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Punching and Electroporation for Enhanced Transdermal Drug Delivery.
    Yang G; Zhang Y; Gu Z
    Theranostics; 2018; 8(13):3688-3690. PubMed ID: 30026875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of skin barrier function using direct current I: effects of conductivity, voltage, distance between electrodes and electrode area.
    Kanebako M; Inagi T; Takayama K
    Biol Pharm Bull; 2002 Nov; 25(11):1456-60. PubMed ID: 12419959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Local temperature rises influence in vivo electroporation pore development: a numerical stratum corneum lipid phase transition model.
    Becker SM; Kuznetsov AV
    J Biomech Eng; 2007 Oct; 129(5):712-21. PubMed ID: 17887897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental Factors to Be Considered in Electroporation-Mediated Transdermal Diffusion Experiments.
    Pavšelj N; Zorec B; Miklavčič D; Becker S
    J Biomech Eng; 2015 Dec; 137(12):124501. PubMed ID: 26458195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.